Get started
Author

Rie Nadia Asso

Observed names: R. ASSO, R. Asso, R.N. Asso, Rie Asso, Rie N. Asso
ORCID: 0000-0003-2361-8439
Observed ORCID: 0000-0003-2361-8439
OpenAlex ID: A5035562913
Frameless Image-Guided Radiosurgery for Multiple Brain Metastasis Using VMAT: A Review and an Institutional Experience
2019 · Samir Abdallah Hanna, Anselmo Mancini, et al. · Frontiers in Oncology · 39
PDF
Brazilian Validation of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (QLG) Computerised Adaptive Tests (CAT) Core
2021 · Gustavo Nader Marta, Tomás Y. T. de Souza, et al. · Current Oncology · 5
PDF
Radiosurgery for multiple brain metastases using volumetric modulated arc therapy: a single institutional series
2022 · Rie Nadia Asso, Anselmo Mancini, et al. · Reports of Practical Oncology & Radiotherapy · 4
Neutrophil-to-lymphocyte ratio for the prediction of soft tissue sarcomas response to pre-operative radiation therapy
2024 · Constanza Martinez, Rie N. Asso, et al. · Radiotherapy and Oncology · 3
Postoperative radiotherapy in prostate cancer: When and how? – An update review
2022 · R.N. Asso, F.A.M. Degrande, et al. · Cancer/Radiothérapie · 3
Toxicity of Patients with Ultra-Central Thoracic Tumors Treated with Stereotactic Body Radiotherapy (SBRT) with Dose of 50 Gy in 5 Fractions
2023 · R.N. Asso, N. Kopek, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
PDF
Radiosurgery for Multiple Brain Metastases using Volumetric Modulated Arc Therapy: Clinical Outcomes and Toxicity from a Single-Institutional Series
2020 · R. Asso, A. Mancini, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
Leptin for overweight and obesity
2016 · Rie Nadia Asso, Maelly RM Ikuno, et al. · Cochrane Database of Systematic Reviews · 1
Avaliação das visitas domiciliárias por estudantes e pelas famílias: uma visão de quem as realiza e de quem as recebe
2013 · Rie Nadia Asso, Vivian Regina Affonso, et al. · Revista Brasileira de Educação Médica · 1
PDF
Assessment of toxicity in patients with ultra-central thoracic tumours treated with stereotactic body radiotherapy with a dose of 50 Gy in 5 fractions
2025 · Rie Nadia Asso, Neil Kopek, et al. · Reports of Practical Oncology & Radiotherapy
PDF
Hypofractionated Intensity Modulated Radiation Therapy and Weekly Gemcitabine for Muscle Invasive Bladder Cancer. Long-Term Results
2024 · T.Y.T. De Souza, L. Souhami, et al. · International Journal of Radiation Oncology*Biology*Physics
24 Hypofractionated Intensity Modulated Radiation Therapy and Weekly Gemcitabine is an Effective and Safe Curative Treatment in Muscle Invasive Bladder Cancer: Long-Term Results
2024 · Tomás Yokoo Teodoro de Souza, Luis Souhami, et al. · Radiotherapy and Oncology
3248: Hypofractionated radiation therapy for prostate cancer in low and middle-income countries
2024 · Rie Nadia Asso, Horacio Patrocinio, et al. · Radiotherapy and Oncology
Hypofractionated Preoperative Radiotherapy 30Gy in Five Fractions for Soft Tissue Sarcoma of the Extremity
2023 · R.N. Asso, F. Cury, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Post-Hypofractionated Radiotherapy Neutrophil-to-Lymphocyte Ratio in Soft Tissue Sarcomas is a Prognostic Biomarker of Recurrence and Distant Metastases
2023 · C. Martinez, R.N. Asso, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
74 Hypofractionated Preoperative Radiotherapy 30GY in 5 Fractions for Soft Tissue Sarcoma of the Extremity
2023 · Rie Asso, Fabio Cury, et al. · Radiotherapy and Oncology
207 Toxicity and Clinical Outcomes to Abdominal Radiotherapy Using 5 Fractions for Non-Surgical Patients
2023 · Rie Asso, Fabio Cury, et al. · Radiotherapy and Oncology
174 Neutrophil-To-Lymphocyte Ratio Post-Hypofractionated Radiation Therapy in Soft Tissue Sarcomas is a Prognostic Biomarker for Recurrence and Metastases
2023 · Constanza Martinez, Rie Asso, et al. · Radiotherapy and Oncology
217 Toxicity of Patients with Ultra-Central Thoracic Tumours Treated with Stereotactic Body Radiotherapy with Dose of 50GY in 5 Fractions
2023 · Rie Asso, Neil Kopek, et al. · Radiotherapy and Oncology
PO-1444 Dynamic neutrophil-to-lymphocyte ratio - a new predictive biomarker for recurrent sarcomas?
2023 · C. Martinez, F. Cury, et al. · Radiotherapy and Oncology
PO-1376 Neoadjuvant radiotherapy after chemotherapy for borderline resectable pancreas cancer
2023 · R. ASSO, I. Gerard, et al. · Radiotherapy and Oncology
PO-1584 Toxicity and clinical outcomes to abdominal radiotherapy using 5 fractions for non-surgical patients
2023 · R. ASSO, F. Cury, et al. · Radiotherapy and Oncology
122: Assessment of the Usage of Hypofractionation for Prostate Cancer in an LMIC Before and After the COVID-19 Pandemic
2022 · Rie Asso, Horacio Patrocinio, et al. · Radiotherapy and Oncology
PDF
Hipofracionamento no tratamento do câncer de próstata no Brasil
2021 · Rie Nadia Asso, Horacio Patrocinio, et al. · Brazilian Journal of Oncology
Implicações da radioterapia de precisão para o cirurgião
2021 · João Luis Fernandes da Silva, Rie Nadia Asso, et al.
Works count: 31
Citation count: 58
H-index: 3
I10-index: 1
Year
Topic
Type